1. Pink Sheet

McKinsey's Overlapping Work For FDA, Opioid Makers Raises Conflict Of Interest Questions

 
• By Brenda Sandburg

A House Oversight and Reform Committee report says McKinsey consultants advised the FDA on modernization of its new drugs regulatory program, the Sentinel Initiative, and other projects at the same time it was working for opioid manufacturers on related topics; agency says McKinsey did not inform it of potential conflicts of interest.

McKinsey & Company
Congressional report describes McKinsey's work with FDA and opioid manufacturers • Source: Alamy

McKinsey and Co.’s simultaneous work for the US Food and Drug Administration and opioid manufacturers raises questions about the transparency in contracts between private consulting firms and the FDA, as well as the procedures in place to avoid conflicts of interest.

In a report released 13 April, the House Oversight and Reform Committee describes projects McKinsey consultants conducted for the FDA that involve topics impacting Purdue Pharma L.P. and other opioid manufacturers the firm was advising

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership